Stuart Collinson

Stuart Collinson is a seasoned professional with extensive experience in the pharmaceutical and biotechnology sectors. Since 2002, Stuart has served as a Partner at Forward Ventures. Stuart held the position of Executive Chair at Tioga Pharmaceuticals, Inc. from 2005 to 2025 and acted as an Advisor and shareholder at ZoBio from 2001 to 2024. Stuart briefly served as CEO at Coho Therapeutics in 2022 and held leadership roles such as Chair and CEO at OxStem from 2019 to 2021, and Director at Soleno Therapeutics, Inc. from 2017 to 2020. Other notable positions include Executive Chair at Arcturus Therapeutics between 2014 and 2018, Director at Essentialis from 2006 to 2017, Chair at Affinium Pharmaceuticals from 2007 to 2014, and Director at Oxagen from 2001 to 2012. Stuart's academic background includes an MBA from Harvard University, a PhD in Physical Chemistry from the University of Oxford, and a BSc in Chemistry from Durham University.